(Q30414626)

21 June 2017

title

Health and economic impact of the seasonal influenza vaccination programme in England (English)

1 reference

21 June 2017

Marc Baguelin

1

0 references

Mark Jit

series ordinal

2

object named as

Mark Jit

1 reference

21 June 2017

3

Elizabeth Miller

1 reference

21 June 2017

William John Edmunds

4

1 reference

21 June 2017

language of work or name

English

0 references

publication date

22 March 2012

1 reference

21 June 2017

1 reference

21 June 2017

volume

30

1 reference

21 June 2017

issue

23

1 reference

21 June 2017

page(s)

3459-3462

1 reference

Systematic review and economic decision modelling for the prevention and treatment of influenza A and B.

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.019

The cost-effectiveness of influenza vaccination of healthy adults 50-64 years of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.019

Clinical and economic impact of influenza vaccination on healthy children aged 2–5 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.019

Cost-Effectiveness of Adjuvanted Influenza Vaccination of Healthy Children 6 to 60 Months of Age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.019

Influenza vaccine uptake and distribution in England and Wales using data from the General Practice Research Database, 1989/90-2003/04.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.019

Estimating influenza vaccine effectiveness using routinely collected laboratory data.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.019

Time lines of infection and disease in human influenza: a review of volunteer challenge studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.019

Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.019

Assessing the burden of influenza and other respiratory infections in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.019

Internet-based surveillance of Influenza-like-illness in the UK during the 2009 H1N1 influenza pandemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.019

Variations in population health status: results from a United Kingdom national questionnaire survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.019

The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.019

Effectiveness of influenza vaccination in the United kingdom, 1996-2007.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.019

English mortality from A/H1N1. Comparisons with recent flu mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.019

The impact of pandemic influenza H1N1 on health-related quality of life: a prospective population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.019

10.1016/J.VACCINE.2012.03.019

7 January 2021

Identifiers

DOI

1 reference

21 June 2017

1 reference